We understand that the impact of heart disease is greater in some communities. Genetics plays a part, but unequal access to great health care is also a factor. At Providence, we make sure each of our patients has access to the best heart care. As part of this commitment, we offer translation services and print publications in multiple languages for our non-English-speaking patients. In keeping with our Mission, Providence offers financial assistance programs that provide free and low-cost care to those who are eligible.

We also prioritize community heart-health awareness through local events and outreach. One example is our Health Equity Hypertension partnership with the American Heart Association.

We value, respect and support the racial, ethnic, religious, spiritual, gender and sexual identities of each member of our diverse community. We aim to treat every patient equally and with dignity – whoever you are, and wherever you are in your journey.

Providence Heart & Vascular Institute of Los Angeles is at the forefront of cardiovascular treatment and therapies. One of our hospitals was the first of two in the world to enroll patients in a clinical trial for a novel stroke prevention device. We were also the first in the nation to complete a commercial implant of WATCHMAN. Both the clinical trial and the WATCHMAN device help reduce the risk of stroke in patients with atrial fibrillation.

As our patient, you can take part in one of our many clinical trials. These include FDA-regulated trials to develop new cardiovascular therapies. Providence also participates in national cardiovascular data registries to continually improve outcomes and patient care.